Nothing Special   »   [go: up one dir, main page]

EP2283854A3 - Polypeptides et polynucleotides de Phorphorymonas gingivalis - Google Patents

Polypeptides et polynucleotides de Phorphorymonas gingivalis Download PDF

Info

Publication number
EP2283854A3
EP2283854A3 EP10185564A EP10185564A EP2283854A3 EP 2283854 A3 EP2283854 A3 EP 2283854A3 EP 10185564 A EP10185564 A EP 10185564A EP 10185564 A EP10185564 A EP 10185564A EP 2283854 A3 EP2283854 A3 EP 2283854A3
Authority
EP
European Patent Office
Prior art keywords
seq
polynucleotides
acid sequence
amino acid
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10185564A
Other languages
German (de)
English (en)
Other versions
EP2283854A2 (fr
Inventor
Bruce Carter Ross
Ian George Barr
Michelle Anne Patterson
Catherine Therese Agius
Linda Joy Rothel
Mai Brigid Margetts
Dianna Margaret Hocking
Elizabeth Ann Webb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Ltd
University of Melbourne
Original Assignee
CSL Ltd
University of Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP0839A external-priority patent/AUPP083997A0/en
Priority claimed from AUPP1182A external-priority patent/AUPP118297A0/en
Priority claimed from AUPP1546A external-priority patent/AUPP154698A0/en
Priority claimed from AUPP2264A external-priority patent/AUPP226498A0/en
Priority claimed from AUPP2911A external-priority patent/AUPP291198A0/en
Priority claimed from AUPP3128A external-priority patent/AUPP312898A0/en
Priority claimed from AUPP3338A external-priority patent/AUPP333898A0/en
Priority claimed from AUPP3654A external-priority patent/AUPP365498A0/en
Priority claimed from AUPP4917A external-priority patent/AUPP491798A0/en
Priority claimed from AUPP4963A external-priority patent/AUPP496398A0/en
Priority claimed from AUPP5028A external-priority patent/AUPP502898A0/en
Application filed by CSL Ltd, University of Melbourne filed Critical CSL Ltd
Publication of EP2283854A2 publication Critical patent/EP2283854A2/fr
Publication of EP2283854A3 publication Critical patent/EP2283854A3/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
EP10185564A 1997-12-10 1998-12-10 Polypeptides et polynucleotides de Phorphorymonas gingivalis Withdrawn EP2283854A3 (fr)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
AUPP0839A AUPP083997A0 (en) 1997-12-10 1997-12-10 Porphyromonas gingivalis nucleotides
AUPP1182A AUPP118297A0 (en) 1997-12-31 1997-12-31 P. gingivalis sequences
AUPP1546A AUPP154698A0 (en) 1998-01-30 1998-01-30 P. gingivalis sequences
AUPP2264A AUPP226498A0 (en) 1998-03-10 1998-03-10 Porphyromonas gingivalis probes and polypeptides
AUPP2911A AUPP291198A0 (en) 1998-04-09 1998-04-09 P. gingivalis sequences
AUPP3128A AUPP312898A0 (en) 1998-04-23 1998-04-23 Porphyromonas gingivalis antigens and probes
AUPP3338A AUPP333898A0 (en) 1998-05-05 1998-05-05 P. gingivalis sequences
AUPP3654A AUPP365498A0 (en) 1998-05-22 1998-05-22 P. gingivalis sequences
AUPP4917A AUPP491798A0 (en) 1998-07-29 1998-07-29 P.gingivalis nucleotides and polypeptides
AUPP4963A AUPP496398A0 (en) 1998-07-30 1998-07-30 P.gingivalis polypeptides
AUPP5028A AUPP502898A0 (en) 1998-08-04 1998-08-04 P.gingivalis antigens
EP06008722A EP1681350A3 (fr) 1997-12-10 1998-12-10 Polypeptides et polynucleotides de Phorphorymonas gingivalis
EP98960880A EP1037999A4 (fr) 1997-12-10 1998-12-10 Polypeptides et nucleotides porphyromonas gingivalis
EP08100586A EP1908772B1 (fr) 1997-12-10 1998-12-10 Polypeptides et polynucleotides de Phorphorymonas gingivalis

Related Parent Applications (3)

Application Number Title Priority Date Filing Date
EP98960880.7 Division 1998-12-10
EP06008722.8 Division 2006-04-27
EP08100586.0 Division 2008-01-17

Publications (2)

Publication Number Publication Date
EP2283854A2 EP2283854A2 (fr) 2011-02-16
EP2283854A3 true EP2283854A3 (fr) 2011-04-06

Family

ID=27581380

Family Applications (10)

Application Number Title Priority Date Filing Date
EP10177405A Withdrawn EP2256204A1 (fr) 1997-12-10 1998-12-10 Polypeptides et polynucleotides de Phorphorymonas gingivalis
EP06008722A Withdrawn EP1681350A3 (fr) 1997-12-10 1998-12-10 Polypeptides et polynucleotides de Phorphorymonas gingivalis
EP10185525A Withdrawn EP2283853A3 (fr) 1997-12-10 1998-12-10 Polypeptides et polynucleotides de phorphorymonas gingivalis
EP08100586A Expired - Lifetime EP1908772B1 (fr) 1997-12-10 1998-12-10 Polypeptides et polynucleotides de Phorphorymonas gingivalis
EP98960880A Withdrawn EP1037999A4 (fr) 1997-12-10 1998-12-10 Polypeptides et nucleotides porphyromonas gingivalis
EP10185564A Withdrawn EP2283854A3 (fr) 1997-12-10 1998-12-10 Polypeptides et polynucleotides de Phorphorymonas gingivalis
EP10185620A Withdrawn EP2283855A3 (fr) 1997-12-10 1998-12-10 Porphorymonas gingivalis polypeptides and polynucleotides
EP10177423A Withdrawn EP2264176A1 (fr) 1997-12-10 1998-12-10 Polypeptides et polynucleotides de Phorphorymonas gingivalis
EP10177457A Expired - Lifetime EP2256205B1 (fr) 1997-12-10 1998-12-10 Polypeptides et polynucleotides de Phorphorymonas gingivalis
EP10185466A Withdrawn EP2283852A3 (fr) 1997-12-10 1998-12-10 Polypeptides et polynucleotides de Phorphorymonas gingivalis

Family Applications Before (5)

Application Number Title Priority Date Filing Date
EP10177405A Withdrawn EP2256204A1 (fr) 1997-12-10 1998-12-10 Polypeptides et polynucleotides de Phorphorymonas gingivalis
EP06008722A Withdrawn EP1681350A3 (fr) 1997-12-10 1998-12-10 Polypeptides et polynucleotides de Phorphorymonas gingivalis
EP10185525A Withdrawn EP2283853A3 (fr) 1997-12-10 1998-12-10 Polypeptides et polynucleotides de phorphorymonas gingivalis
EP08100586A Expired - Lifetime EP1908772B1 (fr) 1997-12-10 1998-12-10 Polypeptides et polynucleotides de Phorphorymonas gingivalis
EP98960880A Withdrawn EP1037999A4 (fr) 1997-12-10 1998-12-10 Polypeptides et nucleotides porphyromonas gingivalis

Family Applications After (4)

Application Number Title Priority Date Filing Date
EP10185620A Withdrawn EP2283855A3 (fr) 1997-12-10 1998-12-10 Porphorymonas gingivalis polypeptides and polynucleotides
EP10177423A Withdrawn EP2264176A1 (fr) 1997-12-10 1998-12-10 Polypeptides et polynucleotides de Phorphorymonas gingivalis
EP10177457A Expired - Lifetime EP2256205B1 (fr) 1997-12-10 1998-12-10 Polypeptides et polynucleotides de Phorphorymonas gingivalis
EP10185466A Withdrawn EP2283852A3 (fr) 1997-12-10 1998-12-10 Polypeptides et polynucleotides de Phorphorymonas gingivalis

Country Status (10)

Country Link
EP (10) EP2256204A1 (fr)
JP (2) JP2001526035A (fr)
KR (1) KR100603552B1 (fr)
AT (1) ATE534742T1 (fr)
AU (1) AU1648799A (fr)
CA (1) CA2313823A1 (fr)
DK (2) DK2256205T3 (fr)
ES (2) ES2419664T3 (fr)
NZ (1) NZ504811A (fr)
WO (1) WO1999029870A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833262B1 (en) 1999-04-21 2004-12-21 University Of Georgia Research Foundation, Inc. Polypeptide having amidolytic activity for a serpin
WO2000063394A2 (fr) * 1999-04-21 2000-10-26 The University Of Georgia Research Foundation, Inc. Un polypeptide presentant une activite amidolytique vis-a-vis d'une serpine
AUPQ485999A0 (en) * 1999-12-24 2000-02-03 Csl Limited P. gingivalis antigenic composition
AU2001252042B2 (en) * 2000-04-28 2005-12-01 Csl Limited Porphyromonas gingivalis recombinant proteins and truncations
AUPQ718200A0 (en) * 2000-04-28 2000-05-25 Csl Limited Porphyromonas gingivalis recombinant proteins and truncations
JP2003192616A (ja) * 2001-12-27 2003-07-09 Univ Nihon 歯周病用ｄｎａワクチン
AU2004266213A1 (en) * 2003-08-15 2005-03-03 University Of Florida Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
GB0411150D0 (en) * 2004-05-19 2004-06-23 Queen Mary & Westfield College Vaccine
AU2007264402B2 (en) * 2006-06-27 2012-09-20 Oral Health Australia Pty Ltd Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease
NZ605037A (en) * 2007-07-12 2014-05-30 Oral Health Australia Pty Ltd Immunology treatment for biofilms
AU2013203250B2 (en) * 2007-07-12 2014-11-13 Oral Health Australia Pty Ltd Immunology treatment for biofilms
US8241611B2 (en) * 2007-07-12 2012-08-14 Oral Health Austrailia Pty. Ltd. Biofilm treatment
US9366673B2 (en) * 2009-08-02 2016-06-14 Sanofi Pasteur Limited Porphyromonas gingivalis polypeptides
EP3139167B1 (fr) 2010-12-15 2018-09-26 Sunstar Inc. Trousse de test pour un titre d'anticorps du plasma ou du sérum contre des bactéries provoquant une parodontopathie
JP6310631B2 (ja) * 2011-10-18 2018-04-11 サンスター株式会社 歯周病原菌血漿または血清抗体価検査キット
BR112019005935A2 (pt) * 2016-09-29 2019-06-11 Meharry Medical College inibidores bacterianos
CN111172177B (zh) * 2019-07-30 2023-08-08 镇江市江澜绿洲生物技术有限公司 cra4S1基因及其编码的蛋白和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5523390A (en) * 1993-09-10 1996-06-04 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
WO1996017936A2 (fr) * 1994-12-09 1996-06-13 University Of Florida Genes clones de porphyromonas gingivalis et sondes de detection de paradontopathie
EP0726314A1 (fr) * 1993-10-08 1996-08-14 Lion Corporation PROTEINE FIMBRILLINE DE $i(PORPHYROMONAS GINGIVALIS)
WO1997016542A1 (fr) * 1995-10-30 1997-05-09 The University Of Melbourne Diagnostics et traitements de maladies periodontiques
WO1998049192A1 (fr) * 1997-04-30 1998-11-05 The University Of Melbourne PRODUITS DE SYNTHESE PEPTIDIQUES PERMETTANT LE DIAGNOSTIC ET LE TRAITEMENT DE LA DESMODONTITE ASSOCIEE A LA $i(PORPHYROMONAS GINGIVALIS)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047238A (en) 1983-06-15 1991-09-10 American Home Products Corporation Adjuvants for vaccines
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5798224A (en) * 1992-12-29 1998-08-25 Doheny Eye Institute Nucleic acids encoding protocadherin
US5643781A (en) * 1992-12-29 1997-07-01 Doheny Eye Institute DNA encoding protocadherin-42
US5475097A (en) 1993-10-21 1995-12-12 University Of Georgia Research Foundation, Inc. Lysine-specific Porphyromonas gingivalis proteinase
AUPN015794A0 (en) 1994-12-20 1995-01-19 Csl Limited Variants of human papilloma virus antigens
AU742668B2 (en) * 1996-03-22 2002-01-10 Morehouse School Of Medicine Immunogenic compositions comprising porphyromonas gingivalis peptides and methods
AUPN901296A0 (en) * 1996-03-29 1996-04-26 University Of Melbourne, The Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5523390A (en) * 1993-09-10 1996-06-04 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
EP0726314A1 (fr) * 1993-10-08 1996-08-14 Lion Corporation PROTEINE FIMBRILLINE DE $i(PORPHYROMONAS GINGIVALIS)
WO1996017936A2 (fr) * 1994-12-09 1996-06-13 University Of Florida Genes clones de porphyromonas gingivalis et sondes de detection de paradontopathie
WO1997016542A1 (fr) * 1995-10-30 1997-05-09 The University Of Melbourne Diagnostics et traitements de maladies periodontiques
WO1998049192A1 (fr) * 1997-04-30 1998-11-05 The University Of Melbourne PRODUITS DE SYNTHESE PEPTIDIQUES PERMETTANT LE DIAGNOSTIC ET LE TRAITEMENT DE LA DESMODONTITE ASSOCIEE A LA $i(PORPHYROMONAS GINGIVALIS)

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
MILLAR D J ET AL: "Production and characterisation of monoclonal antibodies to the principle sonicate antigens of Porphyromonas gingivalis w50", FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY 1993 NETHERLANDS, vol. 7, no. 3, 1993, pages 211 - 222, XP023924432, ISSN: 0928-8244 *
NAKAYAMA K ET AL: "CONSTRUCTION AND CHARACTERIZATION OF ARGININE-SPECIFIC CYSTEINE PROTEINASE (ARG-GINGIPAIN)-DEFICIENT MUTANTS OF PORPHYROMONAS GINGIVALIS", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, INC, US LNKD- DOI:10.1074/JBC.270.40.23619, vol. 270, no. 40, 6 October 1995 (1995-10-06), pages 23619 - 23626, XP001150726, ISSN: 0021-9258 *
NELSON K E ET AL: "Complete genome sequence of the oral pathogenic Bacterium porphyromonas gingivalis strain W83", JOURNAL OF BACTERIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC; US LNKD- DOI:10.1128/JB.185.18.5591-5601.2003, vol. 185, no. 18, 1 September 2003 (2003-09-01), pages 5591 - 5601, XP002320223, ISSN: 0021-9193 *
POTEMPA J ET AL: "Comparative properties of two cysteine proteinases (gingipains R), the products of two related but individual genes of Porphyromonas gingivalis", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, INC, US LNKD- DOI:10.1074/JBC.273.34.21648, vol. 273, no. 34, 21 August 1998 (1998-08-21), pages 21648 - 21657, XP002485021, ISSN: 0021-9258 *
ROSS B C ET AL: "Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis", VACCINE, ELSEVIER LTD, GB, vol. 19, no. 30, 20 July 2001 (2001-07-20), pages 4135 - 4142, XP027322067, ISSN: 0264-410X, [retrieved on 20010720] *
SLAKESKI NADA ET AL: "Characterization of a second cell-associated Arg-specific cysteine proteinase of Porphyromonas gingivalis and identification of an adhesin-binding motif involved in association of the prtR and prtK proteinases and adhesins into large complexes", MICROBIOLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, READING, GB, vol. 144, no. 6, 1 June 1998 (1998-06-01), pages 1583 - 1592, XP002215376, ISSN: 1350-0872 *

Also Published As

Publication number Publication date
EP2283855A3 (fr) 2011-05-04
DK1908772T3 (da) 2012-03-19
JP2009136300A (ja) 2009-06-25
EP2283852A2 (fr) 2011-02-16
ES2377751T3 (es) 2012-03-30
KR20010033030A (ko) 2001-04-25
CA2313823A1 (fr) 1999-06-17
JP5349070B2 (ja) 2013-11-20
EP1037999A4 (fr) 2005-03-23
EP1681350A3 (fr) 2007-07-18
WO1999029870A1 (fr) 1999-06-17
EP1908772B1 (fr) 2011-11-23
EP2283853A3 (fr) 2011-05-11
EP1037999A1 (fr) 2000-09-27
EP2283853A2 (fr) 2011-02-16
EP2283852A3 (fr) 2011-05-04
EP2256205B1 (fr) 2013-04-03
ES2419664T3 (es) 2013-08-21
EP1681350A2 (fr) 2006-07-19
EP2283855A2 (fr) 2011-02-16
EP2264176A1 (fr) 2010-12-22
NZ504811A (en) 2003-10-31
KR100603552B1 (ko) 2006-07-20
DK2256205T3 (da) 2013-07-08
EP1908772A2 (fr) 2008-04-09
EP2283854A2 (fr) 2011-02-16
EP2256204A1 (fr) 2010-12-01
EP1908772A3 (fr) 2008-12-03
JP2001526035A (ja) 2001-12-18
ATE534742T1 (de) 2011-12-15
AU1648799A (en) 1999-06-28
EP2256205A1 (fr) 2010-12-01

Similar Documents

Publication Publication Date Title
EP2283852A3 (fr) Polypeptides et polynucleotides de Phorphorymonas gingivalis
IL205233A0 (en) A polypeptide comprising the amino acid sequence of osteoprotegerin from residues 22 to 401 inclusive, or a fragment or trunaction thereof
EP1714971A3 (fr) Recombinaison dirigée de l'ADN à médiation par transition
AUPP051497A0 (en) Antimicrobial peptides
EP1510524A3 (fr) Composés et peptides se liant au récepteur de l'erythropoietine
EP2261339A3 (fr) Antigènes de Neisseria meningitidis et compositions
CA2295999A1 (fr) Proteines nik, acides nucleiques et procedes correspondants
EP1939293A3 (fr) Protéine ZCYTO21 d'interféron
EP1762619A3 (fr) Genes de croissance aberrante presnets dans de multiples tumeurs
CA2177827A1 (fr) Nouvelles proteines modulant l'apoptose, adn codant pour ces proteines, et leur mode d'utilisation
IL135687A0 (en) A novel human checkpoint kinase, hcds1, compositions and methods
EP1762574A3 (fr) Modification chimique de protéines pour améliorer la biocompatibilité et la bioactivité
EP1006126A3 (fr) Peptide possedant une activité ostéogénique
EP1500700A3 (fr) Lyase d'acide pectique
EP0816504A3 (fr) Facteur d'activation des plaquettes acétylhydrolase, et gène codant celui-ci
CA2071950A1 (fr) Proteine fixatrice du collagene et sa preparation
CA2253006A1 (fr) Gene hydroxylase de beta-carotene
EP0844252A3 (fr) Peptides cycliques ayant une extrémité destinée à un couplage chimique ultérieur et leurs procédés de préparation
CA2197651A1 (fr) Or-1, recepteur orphelin appartenant a la famille des recepteurs nucleaires
AU2161699A (en) Peptides and nucleic acids derived from (eisenia foetida) and the use thereof
CA2259640A1 (fr) Vecteur de glycine humaine
EP0858808A3 (fr) Peptides applicables au traitement de lésions
AU6483896A (en) Nucleotide and amino acid sequence and uses thereof
WO2000029564A3 (fr) Transporteur de glycine humain type 2
CA2163805A1 (fr) Nouveau facteur d'activation des leucocytes

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AC Divisional application: reference to earlier application

Ref document number: 1908772

Country of ref document: EP

Kind code of ref document: P

Ref document number: 1681350

Country of ref document: EP

Kind code of ref document: P

Ref document number: 1037999

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 39/00 20060101ALI20110921BHEP

Ipc: C07K 14/195 20060101ALI20110921BHEP

Ipc: A61K 38/16 20060101AFI20110921BHEP

Ipc: C12N 15/31 20060101ALI20110921BHEP

Ipc: A61P 1/02 20060101ALI20110921BHEP

Ipc: C12Q 1/68 20060101ALI20110921BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20111007